FILANA THERAPEUTICS, INC.
Last · —$0.7316-0.0084 (-1.14%)live · yahoo · 2h ago
Market cap$35.34M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-12
- Operating Cf Burn
- Cash Runway Medium
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Medium — Cash runway ~3.0 years
- Accumulated Deficit High — Accumulated deficit / equity 667%
Upcoming earnings
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.24
Est. revenue
0
Press & signals
- GlobeNewswire
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
- GlobeNewswire
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
Documents
FormReporting forFiledFlags